| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 29, 2021Clinical Trial Demonstrates Procedural Efficiencies, Safety, Effectiveness and Non-Inferiority of DiamondTemp System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system...
-
Jan 14, 2021
ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtronic...
-
Dec 15, 2020The OPuS One Clinical Study is the largest study with the most meaningful clinical results supporting the OsteoCool™ Technology to-date
Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as...
-
Nov 30, 2020- New Commitment Includes Nearly $4 Million for Health Workers, Mental Health, Food Assistance, and Critical Services in Black, Indigenous and People of Color (BIPOC) Communities
With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an additional $3.8 million commitment to provide healthcare...
-
Oct 29, 2020New Technologies Address Most Common Challenges During Head and Neck Surgery
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...
-
Oct 20, 2020Study Reports 84% Back Pain Responder Rate and 69% Profound Responder Rate at 12 Months(1)
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month results from a large, multicenter randomized controlled trial (RCT) that...
-
Oct 9, 2020In Partnership with the Medtronic Foundation, More Than 400,000 KN95 Respirators and 1.1 Million Surgical Masks to be Distributed to Healthcare Facilities Across Continental U.S. and Puerto Rico
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has donated nearly $1 million worth of personal protective equipment (PPE) to relief organization...
-
Aug 5, 2020First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland Clinic
DUBLIN, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that its recently FDA-approved InterStim™ Micro neurostimulator for...
-
Aug 3, 2020World’s Smallest Rechargeable Bladder/Bowel Control System — InterStim Micro — Features Trusted MRI Technology for Full-Body 1.5 and 3 Tesla MRI Scans
DUBLIN, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug...
-
Jul 22, 2020Medtronic Foundation Commits to First-of-Its-Kind National Partnership with the Thurgood Marshall College Fund, and to Minneapolis with Support of the Northside Achievement Zone, People’s Center Clinics & Services, Among Others
MINNEAPOLIS, July 22, 2020 (GLOBE NEWSWIRE) -- The Medtronic Foundation today announced a $16 million commitment to partnerships with organizations working to bring about social justice and...
